allow transcription initiation from a yeast promoter lacking its UAS (6, 11, 28, 29). Our model may also explain the isolation of mutations that impair transcription elongation factors, including Spt6, as suppressors of a transcription initiation defect of his4-912␦, an insertion of the long terminal repeat of a Ty retrotransposon in the HIS4 promoter (30, 31). Similar to transcription initiation from within coding regions, suppression of his4-912␦ may also be a case of promoter activation by transcription elongation-mediated chromatin changes that occur in spt6 mutants.
Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation
Bettina Gebert, Wolfgang Fischer, Evelyn Weiss, Reinhard Hoffmann, Rainer Haas*
Helicobacter pylori (Hp) vacuolating cytotoxin VacA induces cellular vacuolation in epithelial cells. We found that VacA could efficiently block proliferation of T cells by inducing a G 1 /S cell cycle arrest. It interfered with the T cell receptor/interleukin-2 (IL-2) signaling pathway at the level of the Ca 2ϩ -calmodulin-dependent phosphatase calcineurin. Nuclear translocation of nuclear factor of activated T cells (NFAT ), a transcription factor acting as a global regulator of immune response genes, was abrogated, resulting in downregulation of IL-2 transcription. VacA partially mimicked the activity of the immunosuppressive drug FK506 by possibly inducing a local immune suppression, explaining the extraordinary chronicity of Hp infections.
Helicobacter pylori (Hp) causes chronic gastritis, peptic ulcer disease, and is an early risk factor for gastric cancer (1) . To establish a chronic infection, Hp possibly evades host responses through the inhibition of antigenspecific T cell proliferation (2) . Major histocompatibility complex (MHC) class IIrestricted, cell-mediated mechanisms control Hp infection (3), and adoptive transfer of CD4 ϩ T cells demonstrated a protective role of T cells (4) . Gastroduodenal disease depends on the expression of major bacterial virulence factors, such as the vacuolating cytotoxin (vacA) or the cag pathogenicity island (cag-PAI). The cag-PAI encodes a type IV secretion system, injecting the bacterial protein CagA into gastric epithelial cells, or professional phagocytes (5, 6) . CagA eventually becomes tyrosine-phosphorylated and activates Ras signaling via the Raf/ Mek/Erk stress kinase pathway to cause epithelial cell proliferation and scattering (7) . VacA, a secreted 95 kD protein, varies in the signal sequence (s1a, s1b, s1c, s2) and/or its middle region (m1, m2) between different Hp strains (8) . Among other functions, VacA selectively inhibits the invariant chain (Ii)-dependent pathway of antigen presentation mediated by the MHC class II (9) and might induce apoptosis in epithelial cells (10) .
To investigate Hp-T cell interactions, Jurkat T cells were infected with different Hp wildtype (wt) strains and isogenic mutants lacking cagA, vacA, or both genes (table S1). A stimulation of bacteria-infected T cells [multiplicity of infection (MOI) of 30] with phytohemagglutinin/phorbol myristate acetate (PHA/PMA) resulted in a strong reduction of Jurkat T cell proliferation (40 to 60%), compared with the stimulated but uninfected control (Fig. 1A) . Also Campylobacter jejuni C64, producing the cytolethal distending toxin (CDT) known to inhibit cell cycle progression in epithelial cells (11) , caused a pronounced proliferation inhibition. But neither C. jejuni C63, with a defective cdt operon, nor Escherichia coli HB101 showed comparable effects (Fig. 1A) . Fresh human peripheral blood lymphocytes (PBLCs) reacted even more dramatically. Activated Hp-infected PBLCs were reduced in their proliferation to the level of resting (nonstimulated) PBLCs (Fig. 1B) Fig. 2A) . Furthermore, m2-VacA-producing strains (Tx30a, SS1, P49) as well as C. jejuni controls did not dramatically affect IL-2 secretion ( Fig. 2A) . Use of an ␣-CD3/CD28 antibody, instead of PMA/ ionomycin for stimulation, produced similar results. A single bacterium per Jurkat T cell (MOI ϭ 1) was already sufficient to cause a 25% reduction in IL-2 secretion, indicating that physiological amounts of VacA could have an efficient suppressive effect on T cell proliferation in vivo (Fig. 2B) . Furthermore, treatment of PBLCs with CCS ϩ also resulted in downregulation of IL-2R␣ surface localization, similar to the treatment of PBLCs with FK506, a drug that blocks the activity of the cellular phosphatase calcineurin (12) (Fig. 2C) .
For gastric adenocarcinoma (AGS) epithelial cells, co-culture with Hp caused cell cycle inhibition from G 1 to S phase (13 (Fig. 2D) . Consequently, the phosphorylation, but not the production of reti- noblastoma protein (Rb) (which is a major downstream target of these cyclins controlling G 1 /S phase progression), was strongly reduced by VacA treatment of PBLCs after 48 hours (Fig. 2D) . Thus, secreted Hp VacA plays a pivotal role in blocking T cell activation and proliferation at the stage of IL-2 signaling and by inducing cell cycle arrest.
To better understand the effect of VacA on IL-2 secretion, luciferase (luc) reporter constructs were used for transfection of Jurkat T cells, demonstrating that VacA efficiently blocked IL-2 production at the transcriptional level (Fig. 3A) . Transcription factors AP-1, nuclear factor kappa B (NF-B), NFAT, and RE/ AP have been identified as essential for activation of the IL-2 gene promoter (14) . Neither the AP-1-luc (Fig. 3B) , nor the NFB-luc (Fig. 3C) or the RE/AP-luc reporter (Fig. 3D) , was downregulated by VacA. However, an NFAT-luc reporter was strongly silenced after treatment of transfected Jurkat cells with Hp P12, but not P12⌬vacA (Fig. 3E) , indicating a transcriptional silencing of the IL-2 gene by targeting the NFAT signaling pathway. Down-regulation of the high-affinity IL-2R␣, the gene of which is also under control of NFAT (15) , supports this observation (Fig. 2C) . CDT seems to use a different strategy (Fig. 3, F and G) by acting as a deoxyribonuclease (DNase) inducing cell cycle arrest by DNA strand breakage (16) .
NFAT represents a family of related transcription factors involved in the coordinate induction of expression of a number of cytokines upon T cell activation. The calcium-activated phosphatase calcineurin unmasks nuclear localization signals on NFAT by dephosphorylation of serine-threonine motifs, resulting in its translocation into the nucleus. A HeLa cell line constitutively expressing a green fluorescent protein (GFP)-NFAT fusion protein (17) showed nuclear GFP-fluorescence upon activation (Fig. 4A) . Hp P12, but not P12⌬vacA, clearly abrogated the nuclear translocation of NFAT in 80% of cells (Fig. 4, A and B ; P12/ P12⌬vacA). Similar data were obtained with Jurkat T cells transiently transfected with the GFP-NFAT-expressing plasmid pAD4 (17) . Thus, VacA inhibits nuclear translocation of NFAT, which explains the failure of T cells to express and secrete IL-2. To determine whether VacA targeted NFAT directly or whether it prevented dephosphorylation of NFAT by blocking calcineurin phosphatase activity, we engineered Jurkat T cells to express a constitutively active form of calcineurin ( pSR␣-⌬CaM-AI). This abrogated the activity of VacA completely (Fig. 4C) , suggesting that VacA did not interact with NFAT directly but blocked the signaling cascade at the level of the phosphatase calcineurin, or further upstream.
FK506 (Tacrolimus) and Cyclosporin A (CsA) are medically important immunosuppressive drugs that inhibit calcineurin activity. Using microarray analysis, a set of 136 genes composed of four groups was determined as differentially regulated (Fig. 4D) (table S3 ). Group 1 genes were up-regulated by both FK506 and VacA, whereas genes in group 2 were downregulated by both compounds. Group 2A consisted of genes strongly suppressed by FK506 but only moderately by VacA, whereas group 2B contained genes equally suppressed by FK506 and VacA. Finally, group 3 comprised genes down-regulated by FK506 but not significantly changed in their expression by VacA. All genes identified as being differently expressed by VacA represented a subgroup also modulated by FK506, supporting our hypothesis that both factors use a common mechanism of gene regulation by blocking calcineurin (fig. S3 ). Whereas VacA neither influenced NFB nor AP-1 transcription factors negatively (Fig. 3, B and C) , FK506 could suppress NFB and AP-1 (18), which might explain its repression of group 3 genes. Among the genes most strongly downregulated (group 2B) were those encoding IL-2 and NFAT, but also genes encoding C-or CC-chemokines, such as single C motif-1 (SCM-1␤), SCM-1␣ (lymphotactin, ATAC), macrophage inflammatory protein (MIP)-1␣, or MIP-1␤. Most of these carry experimentally verified NFAT binding sites (19, 20) .
The approach of using bacterial pathogens or viruses to block T lymphocyte activation and/or proliferation and to induce immune suppression has recently been recognized as a successful strategy in the interaction of microbes with its host (21) . A vacA-negative Hp SS1 mutant is compromised in its ability to initially establish an infection when competing with the corresponding wt strain (22) . However, how might Hp or VacA meet T cells in the gastric mucosa? The number of lamina propria and intraepithelial T cells of the CD4 ϩ and CD8 ϩ subtype are significantly increased in Hp-infected versus noninfected patients (23) , and Hp could directly contact such intraepithelial T cells. Because tight junctions can be opened by Hp (24) , secreted bacterial products such as VacA can be found deep in the lamina propria (25) . Thus, VacA might act as a "long distance weapon" to efficiently block proliferation of T cells in the local gastric environment. For Hp, classified as a type I carcinogen, a mechanism of local immune suppression might also be an important instrument for induction of malignant mucosaassociated lymphoid tissue (MALT) lymphoma and adenocarcinoma of the stomach. In memory consolidation, the memory trace stabilizes and becomes resistant to certain amnesic agents. The textbook account is that for any memorized item, consolidation starts and ends just once. However, evidence has accumulated that upon activation in retrieval, the trace may reconsolidate. Whereas some authors reported transient renewed susceptibility of retrieved memories to consolidation blockers, others could not detect it. Here, we report that in both conditioned taste aversion in the rat and fear conditioning in the medaka fish, the stability of retrieved memory is inversely correlated with the control of behavior by that memory. This result may explain some conflicting findings on reconsolidation of activated memories.
We wanted to further elucidate the neurobiology of experimental extinction, which is the decline in the frequency or intensity of a conditioned response after its retrieval in the absence of the reinforcer (1, 2). We previously reported that in conditioned taste aversion (CTA)-in which taste (conditioned stimulus, CS) is associated with delayed visceral malaise (unconditioned stimulus, US) (3)-microinfusion of anisomycin, a protein synthesis inhibitor, into either the taste cortex (insular cortex) (4) or the basolateral amygdala (5) immediately after retrieval blocks extinction. This is congruent with the notion that extinction is relearning (of a CS-noUS or "inhibitory" association) rather than unlearning (of the CS-US association). Anisomycin, a universal consolidation blocker, did not disrupt the original CS-US trace. A similar effect of protein synthesis inhibition has been reported in inhibitory avoidance, in which extinction was blocked and the original trace spared (6) . This finding contrasts with reports by several authors that application of consolidation blockers in retrieval leads to apparent amnesia of the original trace [ (7) (8) (9) (10) , but see discussions in (11, 12) ]. This discrepancy might be related to the difference in the ability of the retrieval protocol to initiate extinction (13) . Values are means Ϯ SEM of the aversion index, defined as [ml water/(ml water ϩ ml saccharin)] ϫ 100 (4).
(A) After a single training trial, the trace can be extinguished readily (-ani, n ϭ 8); microinfusion of anisomycin into the insular cortex immediately after retrieval (arrow), under conditions that block consolidation of the original trace, blocks extinction (ϩani, n ϭ 31). The data are derived from replication of an experiment reported in (4). (B) After two training trials, 1 day apart, the trace becomes much more resistant to extinction (-ani, n ϭ 36). The effect of microinfusion of anisomycin into the insular cortex immediately after retrieval (arrow), under the conditions of (A), is now reversed; the protein synthesis inhibitor leads to accelerated decline in the behavior guided by the original association (ϩani, n ϭ 27). Inset: Aversion indices on the second test day for the four groups described in (A) and (B) plotted as a function of training intensity. For statistical analysis, see text.
